Acid disrupts barrier function of squamous epithelium
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Gastroesophageal reflux disease (GERD) is caused by reflux of acidic stomach contents into the esophagus. Esophageal epithelium plays an important role in preventing damage to the surrounding tissues through its barrier function. However, it has been difficult to study the factors that lead to epithelial damage and disruption of epithelial barrier function. To systematically study these factors, Oshima et al created an in vitro stratified squamous epithelium model. They took advantage of a recent report that rabbit tracheal epithelial cells can be differentiated into stratified squamous epithelium in vitro. Using an air-liquid culture-interface method, they demonstrated that primary human bronchial cells also differentiated into stratified squamous epithelium in vitro, with many similarities to esophageal squamous epithelium. Furthermore, their model showed a tight barrier at culture day 7. Consistent with barrier function, the model exhibited a distribution of tight junction proteins similar to that observed in normal human esophagus. Interestingly, exposure to acid (pH2) disrupted barrier function and resulted in diminished levels of claudin-4 in the superficial layers. These results indicate that this model recapitulates many of the salient features of esophageal squamous epithelium and should not only provide considerable insight but also potentially serve as a treatment model for GERD and other esophageal diseases.
Epidermal regulation of dermal angiogenesis
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Regulation of dermal angiogenesis is critical for normal aspects of skin physiology. Because the epidermis is juxtaposed between the dermis and the external environment, it has been postulated that it might play an important role in regulating dermal angiogenesis. Supporting this hypothesis is the finding that psoriatic epidermis increases dermal angiogenesis via secretion of vasoactive endothelial growth factor. Furthermore, epidermal hypoxia inducible factor 1 (HIF1) appears to play a role in adaptation to environmental oxygen levels. HIF1, a key regulator of hypoxia in normal physiological and pathological responses, is a heterodimeric transcription factor composed of HIF1α and ARNT (HIF1β) doi:10.1038/labinvest.2011.197 Laboratory Investigation (2012) 92, 2-3that controls an angiogenic transcription program activated under hypoxic conditions. Because ARNT is ubiquitously expressed, it has been thought that HIF1α is the primary regulator of HIF1 action. However, there is increasing evidence that ARNT levels also regulate HIF1 action. Wondimu et al created an epidermis-specific Arnt mouse knockout to parse Arnt's role in regulating dermal angiogenesis. They found that epidermis-specific Arnt knockout mice had increased levels of dermal capillaries and blood vessels, providing further support that epidermal Hif1 regulates dermal angiogenesis. It appears that loss of Arnt1 is partially compensated by increased expression of Arnt2, which can also dimerize with Hif1α. However, the transcriptional profile of Hif1α/Arnt 1 differs from that of Hif1α/Arnt 2, explaining the increase of dermal angiogenesis. Interestingly, this compensatory mechanism suggests that Hif1 epidermal regulation of dermal angiogenesis is a critical regulatory mechanism. Further studies will be required to elucidate the precise role of epidermal Arnt1 in normal dermal angiogenesis and abnormal disease states.
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Breast cancer model resource There is a paucity of in vivo models of breast cancer that authentically recapitulate all the biological features of human breast cancer. To overcome this limitation, DeRose et al, as described in a recent technical report in Nature Medicine, undertook an extensive effort to graft a variety of human breast cancer specimens directly from patients into cleared mammary fat pads of nonobese diabetic severe combined immunodeficient mice. Only 27% of the samples took, but those that did exhibited typical human histology and metastasized to clinically relevant sites at high frequency. The investigators also found that tumors that engrafted were associated with a more aggressive clinical course in the patients from whom the grafts were derived, suggesting that engraftment is an inherent feature of more aggressive breast cancers. 2011;17:1514-1520; doi:10.1038/nm.2454 Delaying aging-associated disorders Advanced age leads to a wide variety of chronic diseases. However, little is known about the precise mechanisms that underlie age-related maladies. In a recent letter in Nature, Baker et al reported their investigation into whether elimination of senescent cells might delay aging-associated disorders. Using a clever transgenic strategy that allowed them to eliminate p16 Ink4a -positive senescent cells in a mouse aging model, they found that clearance of senescent cells delayed the onset of age-related pathologies such as loss of muscle and fat. Clearance of senescent cells also reversed muscle and fat deficits in aged mice that had exhibited significant loss of muscle and adipose tissue. These results clearly suggest that strategies to eliminate senescent cells in humans may delay or reverse age-associated disorders.
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New proteasome inhibitor therapy As recently reported in a letter in Nature Medicine, D' Arcy et al identified a novel compound known as b-AP15 that induces the lysosomal apoptosis pathway. Subsequent analysis revealed that b-AP15 targets the 26S proteasome. Unlike bortezomib-another proteasome inhibitor, which targets the 20S proteolytic core particle-it turns out that b-AP15 targets the 19S regulatory particle. Specifically, b-AP15 inhibits two 19S regulatory-particle-associated deubiquitinases, ubiquitin C-terminal hydrolase 5 and ubiquitin-specific peptidase 14, leading to the accumulation of polyubiquitinated proteins. Cells treated with b-AP15 have stronger expression of chaperone genes, suggesting that the polyubiquitinated proteins are toxic and thus induce apoptosis. Evaluation of b-AP15 demonstrated that it had remarkable antitumor activity in multiple solid-tumor models and an acute myeloid leukemia model in vivo, suggesting that it may have broad anticancer therapeutic activity in human cancers.
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New insights into the pathogenesis of osteoarthritis Osteoarthritis, which is characterized by the breakdown of articular cartilage in synovial joints, has been thought to be caused by "wear and tear. " In a recent letter in Nature Medicine, however, Wang et al present work that challenges this assumption. When they analyzed the synovial fluid of patients with osteoarthritis using mass spectrometry, the authors found an abundance of complement proteins-specifically, those that compose the membrane attack complex-mediated arm of complement. Gene expression analysis revealed that synovial cells were the source of the complement proteins, which activated chondrocytes to produce degradative enzymes that destroyed the joints. Using genetically engineered mice deficient in components of the complement system, they showed that complement-deficient mice were protected from osteoarthritis in three different osteoarthritis models. These results provide a rationale for targeting the complement system in pursuit of a therapy to prevent or lessen the severity of osteoarthritis.
